Literature DB >> 31357060

Chagas disease in the Bolivian Chaco: Persistent transmission indicated by childhood seroscreening study.

Thomas Hopkins1, Raquel Gonçalves2, Janet Mamani3, Orin Courtenay4, Caryn Bern5.   

Abstract

BACKGROUND: Screening for Trypanosoma cruzi infection was performed amongst children in a rural community in the Bolivian Chaco, an area known for high prevalence. The force of infection (FOI) was estimated.
METHODS: A total of 423 children attending the local school were screened using the Chagas Detect Plus (CDP) rapid test (InBios International, Inc.). CDP-positive specimens were further tested by indirect haemagglutination assay (IHA) and Wiener Recombinante v3.0 ELISA. A catalytic model was used to estimate FOI.
RESULTS: Confirmed seroprevalence was 0.22, rising steeply with age. The mean age of seropositive individuals was 13 years. The calculated specificity of the rapid test was 91.9%. The annual incidence estimated from the FOI was 0.021.
CONCLUSIONS: This study demonstrates persistent transmission and continuing high levels of T. cruzi infection in the Bolivian Chaco, and highlights the practicality of school-based screening.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Bolivian Chaco; Chagas disease; Screening study; T. cruzi; Trypanosoma cruzi

Mesh:

Year:  2019        PMID: 31357060     DOI: 10.1016/j.ijid.2019.07.020

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  5 in total

1.  Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission.

Authors:  Antonieta Rojas de Arias; Carlota Monroy; Felipe Guhl; Sergio Sosa-Estani; Walter Souza Santos; Fernando Abad-Franch
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-07-06       Impact factor: 2.747

2.  Evaluation of 2 Lateral Flow Rapid Tests in the Diagnosis of Chagas Disease in the Washington Metropolitan Area.

Authors:  Yagahira E Castro-Sesquen; Antonella Saldaña; Dhayanna Patino Nava; Diana Paulette Evans; Tabitha Bayangos; Kelly DeToy; Alexia Trevino; Rachel Marcus; Caryn Bern; Robert H Gilman; Kawsar R Talaat
Journal:  Open Forum Infect Dis       Date:  2021-03-02       Impact factor: 3.835

3.  Assessing antibody decline after chemotherapy of early chronic Chagas disease patients.

Authors:  Niamh Murphy; M Victoria Cardinal; Tapan Bhattacharyya; Gustavo F Enriquez; Natalia P Macchiaverna; Alejandra Alvedro; Héctor Freilij; Pablo Martinez de Salazar; Israel Molina; Pascal Mertens; Quentin Gilleman; Ricardo E Gürtler; Michael A Miles
Journal:  Parasit Vectors       Date:  2021-10-20       Impact factor: 3.876

4.  Acute Pediatric Chagas Disease in Antioquia, Colombia: A Geographic Location of Suspected Oral Transmission.

Authors:  Lídia Gual-Gonzalez; Catalina Arango-Ferreira; Laura Camila Lopera-Restrepo; Omar Cantillo-Barraza; Daniela Velásquez Marín; Natalia Restrepo Bustamante; Omar Triana-Chavez; Melissa S Nolan
Journal:  Microorganisms       Date:  2021-12-22

5.  Biopharmaceutical Characteristics of Nifurtimox Tablets for Age- and Body Weight-Adjusted Dosing in Patients With Chagas Disease.

Authors:  Heino Stass; Ethel Feleder; Facundo Garcia-Bournissen; Johannes Nagelschmitz; Boris Weimann; Gustavo Yerino; Jaime Altcheh
Journal:  Clin Pharmacol Drug Dev       Date:  2020-10-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.